| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 8 | 2013 | 139 | 1.570 |
Why?
|
| Models, Chemical | 4 | 2006 | 90 | 1.010 |
Why?
|
| Adipose Tissue | 18 | 2018 | 509 | 1.010 |
Why?
|
| Stilbenes | 4 | 2017 | 42 | 0.860 |
Why?
|
| Models, Molecular | 6 | 2013 | 1147 | 0.720 |
Why?
|
| Insulin Resistance | 10 | 2024 | 700 | 0.710 |
Why?
|
| Muscle, Skeletal | 12 | 2024 | 1041 | 0.710 |
Why?
|
| Membrane Potentials | 3 | 2006 | 316 | 0.700 |
Why?
|
| Cell Membrane | 3 | 2006 | 483 | 0.650 |
Why?
|
| Antioxidants | 3 | 2017 | 366 | 0.550 |
Why?
|
| Obesity | 11 | 2020 | 2440 | 0.500 |
Why?
|
| Ion Channel Gating | 2 | 2006 | 125 | 0.480 |
Why?
|
| Nicotinic Agonists | 2 | 2006 | 45 | 0.440 |
Why?
|
| Metabolic Syndrome | 2 | 2017 | 365 | 0.430 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2024 | 1420 | 0.420 |
Why?
|
| Torpedo | 4 | 2013 | 37 | 0.370 |
Why?
|
| Human Growth Hormone | 3 | 2018 | 80 | 0.360 |
Why?
|
| Computer Simulation | 4 | 2006 | 708 | 0.360 |
Why?
|
| Acetylcholine | 2 | 2013 | 86 | 0.350 |
Why?
|
| Binding Sites | 7 | 2013 | 1378 | 0.320 |
Why?
|
| Static Electricity | 5 | 2006 | 47 | 0.280 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2019 | 243 | 0.260 |
Why?
|
| Tubocurarine | 2 | 2006 | 4 | 0.260 |
Why?
|
| Acetylcholinesterase | 1 | 2006 | 26 | 0.250 |
Why?
|
| Body Composition | 4 | 2017 | 563 | 0.250 |
Why?
|
| Fasting | 2 | 2018 | 308 | 0.250 |
Why?
|
| Glucose | 4 | 2024 | 917 | 0.240 |
Why?
|
| Conotoxins | 2 | 2006 | 3 | 0.240 |
Why?
|
| Adipogenesis | 3 | 2021 | 82 | 0.240 |
Why?
|
| Thermogenesis | 2 | 2022 | 52 | 0.230 |
Why?
|
| Insulin | 4 | 2024 | 1245 | 0.230 |
Why?
|
| Inflammation | 5 | 2017 | 1559 | 0.220 |
Why?
|
| Intra-Abdominal Fat | 2 | 2017 | 59 | 0.220 |
Why?
|
| Protein Binding | 8 | 2013 | 1852 | 0.220 |
Why?
|
| Glucosides | 1 | 2024 | 48 | 0.210 |
Why?
|
| Liver | 4 | 2017 | 1860 | 0.210 |
Why?
|
| Vitamin D Deficiency | 2 | 2015 | 76 | 0.210 |
Why?
|
| Benzhydryl Compounds | 1 | 2024 | 68 | 0.210 |
Why?
|
| Fluorescence Resonance Energy Transfer | 4 | 2008 | 72 | 0.200 |
Why?
|
| Vitamin D | 2 | 2015 | 180 | 0.200 |
Why?
|
| Creatine | 1 | 2022 | 40 | 0.200 |
Why?
|
| Thinness | 2 | 2016 | 77 | 0.190 |
Why?
|
| Interleukin-6 | 3 | 2017 | 439 | 0.190 |
Why?
|
| Software | 1 | 2006 | 732 | 0.180 |
Why?
|
| Triglycerides | 5 | 2017 | 616 | 0.180 |
Why?
|
| Rats, Wistar | 9 | 2016 | 398 | 0.180 |
Why?
|
| Models, Biological | 1 | 2006 | 1531 | 0.180 |
Why?
|
| Glucocorticoids | 2 | 2003 | 401 | 0.180 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2021 | 38 | 0.180 |
Why?
|
| Calmodulin | 3 | 2009 | 223 | 0.180 |
Why?
|
| Lipid Metabolism | 2 | 2016 | 386 | 0.180 |
Why?
|
| Absorptiometry, Photon | 3 | 2017 | 206 | 0.180 |
Why?
|
| RNA, Messenger | 8 | 2016 | 2877 | 0.170 |
Why?
|
| Animals | 26 | 2020 | 36217 | 0.170 |
Why?
|
| Muscular Diseases | 1 | 2021 | 116 | 0.170 |
Why?
|
| Progesterone | 1 | 2003 | 636 | 0.170 |
Why?
|
| Fibroblast Growth Factor 6 | 1 | 2020 | 3 | 0.170 |
Why?
|
| Fibroblast Growth Factor 9 | 1 | 2020 | 9 | 0.170 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2020 | 17 | 0.170 |
Why?
|
| Uncoupling Protein 1 | 1 | 2020 | 32 | 0.170 |
Why?
|
| COUP Transcription Factor I | 1 | 2020 | 91 | 0.160 |
Why?
|
| Adipocytes, Brown | 1 | 2020 | 28 | 0.160 |
Why?
|
| Cholesterol | 4 | 2017 | 573 | 0.160 |
Why?
|
| Double-Blind Method | 4 | 2017 | 1661 | 0.160 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2017 | 545 | 0.150 |
Why?
|
| Blotting, Western | 3 | 2017 | 1136 | 0.150 |
Why?
|
| Maternal Exposure | 1 | 2019 | 155 | 0.140 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2017 | 306 | 0.140 |
Why?
|
| Vitamins | 2 | 2015 | 113 | 0.140 |
Why?
|
| Diet, High-Fat | 2 | 2017 | 241 | 0.140 |
Why?
|
| Memory Disorders | 1 | 2020 | 235 | 0.140 |
Why?
|
| Cranial Irradiation | 1 | 2018 | 72 | 0.140 |
Why?
|
| Biopsy | 1 | 2021 | 1204 | 0.140 |
Why?
|
| Blood Glucose | 3 | 2017 | 1185 | 0.140 |
Why?
|
| TRPV Cation Channels | 1 | 2017 | 46 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 288 | 0.140 |
Why?
|
| Fructosamine | 1 | 2017 | 12 | 0.140 |
Why?
|
| Hippocampus | 2 | 2020 | 861 | 0.140 |
Why?
|
| Hypothermia | 1 | 2017 | 64 | 0.130 |
Why?
|
| Quadriceps Muscle | 1 | 2017 | 17 | 0.130 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2017 | 25 | 0.130 |
Why?
|
| White Matter | 1 | 2019 | 212 | 0.130 |
Why?
|
| Physical Conditioning, Animal | 1 | 2018 | 98 | 0.130 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2018 | 338 | 0.130 |
Why?
|
| Cell Differentiation | 2 | 2021 | 2026 | 0.130 |
Why?
|
| Leptin | 2 | 2017 | 222 | 0.130 |
Why?
|
| Calcium Channels, L-Type | 2 | 2009 | 53 | 0.130 |
Why?
|
| Porosity | 2 | 2006 | 44 | 0.130 |
Why?
|
| Spectrometry, Fluorescence | 3 | 2006 | 87 | 0.120 |
Why?
|
| Lipolysis | 1 | 2016 | 83 | 0.120 |
Why?
|
| Neurogenesis | 1 | 2018 | 223 | 0.120 |
Why?
|
| Fetal Development | 1 | 2017 | 135 | 0.120 |
Why?
|
| Weight Gain | 2 | 2017 | 412 | 0.120 |
Why?
|
| Male | 22 | 2020 | 65576 | 0.120 |
Why?
|
| Disease Models, Animal | 5 | 2018 | 4760 | 0.120 |
Why?
|
| Recovery of Function | 1 | 2017 | 463 | 0.120 |
Why?
|
| Cholesterol, HDL | 1 | 2017 | 396 | 0.120 |
Why?
|
| Glucose Intolerance | 1 | 2016 | 85 | 0.120 |
Why?
|
| Brain Ischemia | 1 | 2017 | 278 | 0.120 |
Why?
|
| Diet, Protein-Restricted | 1 | 2016 | 82 | 0.110 |
Why?
|
| Peptides | 3 | 2009 | 863 | 0.110 |
Why?
|
| Glucose Transporter Type 4 | 2 | 2011 | 20 | 0.110 |
Why?
|
| Metabolic Diseases | 2 | 2013 | 139 | 0.110 |
Why?
|
| Stress, Psychological | 1 | 2019 | 601 | 0.110 |
Why?
|
| Muscles | 1 | 2014 | 255 | 0.110 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 470 | 0.110 |
Why?
|
| Kinetics | 2 | 2006 | 1323 | 0.110 |
Why?
|
| Rats | 8 | 2018 | 3851 | 0.110 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 316 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2009 | 329 | 0.110 |
Why?
|
| Quaternary Ammonium Compounds | 2 | 2006 | 34 | 0.110 |
Why?
|
| Cognition Disorders | 1 | 2018 | 578 | 0.100 |
Why?
|
| Blood Pressure | 2 | 2017 | 1411 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 1152 | 0.100 |
Why?
|
| Cholesterol, LDL | 1 | 2017 | 609 | 0.100 |
Why?
|
| Muscle Proteins | 1 | 2016 | 417 | 0.100 |
Why?
|
| Mice | 9 | 2020 | 18936 | 0.100 |
Why?
|
| Eating | 2 | 2008 | 393 | 0.100 |
Why?
|
| Calcium | 3 | 2009 | 1099 | 0.100 |
Why?
|
| Postprandial Period | 1 | 2013 | 91 | 0.100 |
Why?
|
| Structure-Activity Relationship | 2 | 2006 | 607 | 0.100 |
Why?
|
| Meals | 1 | 2013 | 61 | 0.100 |
Why?
|
| Dietary Supplements | 2 | 2015 | 488 | 0.100 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2019 | 252 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 4823 | 0.090 |
Why?
|
| Sweetening Agents | 1 | 2011 | 37 | 0.090 |
Why?
|
| Food Industry | 1 | 2011 | 2 | 0.090 |
Why?
|
| Dietary Sucrose | 1 | 2011 | 42 | 0.090 |
Why?
|
| Trans Fatty Acids | 1 | 2011 | 11 | 0.090 |
Why?
|
| Dexamethasone | 3 | 2003 | 281 | 0.090 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2011 | 42 | 0.090 |
Why?
|
| Hyperlipidemias | 1 | 2013 | 199 | 0.090 |
Why?
|
| Ovariectomy | 3 | 2008 | 189 | 0.090 |
Why?
|
| Endothelium | 1 | 2011 | 70 | 0.090 |
Why?
|
| Ion Channels | 1 | 2012 | 209 | 0.090 |
Why?
|
| Body Weight | 4 | 2016 | 1035 | 0.090 |
Why?
|
| Depression | 1 | 2020 | 1362 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2012 | 256 | 0.090 |
Why?
|
| Fatty Acids | 1 | 2013 | 367 | 0.080 |
Why?
|
| Fatty Liver | 1 | 2012 | 215 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 3869 | 0.080 |
Why?
|
| Fatty Acids, Nonesterified | 3 | 2024 | 137 | 0.080 |
Why?
|
| Signal Transduction | 4 | 2018 | 4917 | 0.080 |
Why?
|
| Interleukin-8 | 2 | 2008 | 214 | 0.080 |
Why?
|
| Stroke | 1 | 2017 | 1079 | 0.080 |
Why?
|
| Humans | 22 | 2024 | 133331 | 0.080 |
Why?
|
| Molecular Conformation | 2 | 2013 | 111 | 0.070 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2008 | 29 | 0.070 |
Why?
|
| Oxidative Stress | 2 | 2011 | 868 | 0.070 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2008 | 19 | 0.070 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2008 | 1 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2008 | 78 | 0.070 |
Why?
|
| Ribonucleotides | 1 | 2008 | 32 | 0.070 |
Why?
|
| Case-Control Studies | 4 | 2018 | 3418 | 0.070 |
Why?
|
| Fluorescent Dyes | 2 | 2006 | 270 | 0.070 |
Why?
|
| Middle Aged | 7 | 2017 | 28977 | 0.070 |
Why?
|
| Protein Conformation | 3 | 2009 | 873 | 0.070 |
Why?
|
| Software Design | 1 | 2006 | 23 | 0.070 |
Why?
|
| Behavior, Animal | 2 | 2020 | 522 | 0.070 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2008 | 176 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 258 | 0.060 |
Why?
|
| Diffusion | 1 | 2006 | 58 | 0.060 |
Why?
|
| Piperidines | 1 | 2008 | 241 | 0.060 |
Why?
|
| Lipoprotein Lipase | 2 | 2003 | 60 | 0.060 |
Why?
|
| Luminescent Measurements | 1 | 2006 | 60 | 0.060 |
Why?
|
| Proadifen | 1 | 2006 | 1 | 0.060 |
Why?
|
| Dansyl Compounds | 1 | 2006 | 4 | 0.060 |
Why?
|
| Phencyclidine | 1 | 2006 | 6 | 0.060 |
Why?
|
| Brain | 1 | 2018 | 3223 | 0.060 |
Why?
|
| Pyrazoles | 1 | 2008 | 334 | 0.060 |
Why?
|
| Calcium Channel Blockers | 1 | 2006 | 116 | 0.060 |
Why?
|
| Cell Separation | 2 | 2021 | 231 | 0.060 |
Why?
|
| Proteins | 2 | 2002 | 1090 | 0.060 |
Why?
|
| Estrogens | 1 | 2008 | 524 | 0.060 |
Why?
|
| Female | 16 | 2020 | 71482 | 0.060 |
Why?
|
| Lipids | 1 | 2008 | 565 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 2785 | 0.060 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2024 | 18 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 492 | 0.050 |
Why?
|
| Body Fat Distribution | 2 | 2016 | 32 | 0.050 |
Why?
|
| Young Adult | 5 | 2018 | 9920 | 0.050 |
Why?
|
| Calcium Channels | 1 | 2004 | 165 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2021 | 815 | 0.050 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2024 | 79 | 0.050 |
Why?
|
| Catecholamines | 1 | 2003 | 57 | 0.050 |
Why?
|
| Sex Factors | 3 | 2016 | 1353 | 0.050 |
Why?
|
| Estradiol | 2 | 2003 | 560 | 0.050 |
Why?
|
| Creatine Kinase | 1 | 2022 | 63 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 606 | 0.050 |
Why?
|
| Thermodynamics | 1 | 2002 | 146 | 0.050 |
Why?
|
| Adiponectin | 3 | 2008 | 128 | 0.050 |
Why?
|
| Adult | 8 | 2018 | 31674 | 0.050 |
Why?
|
| Energy Metabolism | 2 | 2022 | 815 | 0.050 |
Why?
|
| Family Health | 1 | 2002 | 258 | 0.050 |
Why?
|
| Growth Hormone | 1 | 2002 | 150 | 0.050 |
Why?
|
| Adipocytes | 1 | 2022 | 179 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2001 | 192 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 2001 | 177 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2002 | 297 | 0.040 |
Why?
|
| Muscular Atrophy | 1 | 2021 | 91 | 0.040 |
Why?
|
| Pregnancy | 3 | 2019 | 7599 | 0.040 |
Why?
|
| Lysine | 1 | 2001 | 207 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 2125 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2011 | 15 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2011 | 33 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2020 | 87 | 0.040 |
Why?
|
| Time Factors | 4 | 2016 | 6544 | 0.040 |
Why?
|
| Maternal Behavior | 1 | 2019 | 71 | 0.040 |
Why?
|
| Calorimetry, Indirect | 1 | 2018 | 61 | 0.040 |
Why?
|
| Glucose Clamp Technique | 1 | 2018 | 78 | 0.040 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1999 | 103 | 0.040 |
Why?
|
| Risk Factors | 4 | 2015 | 10951 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2013 | 714 | 0.040 |
Why?
|
| Gene Expression | 3 | 2013 | 1608 | 0.040 |
Why?
|
| Rats, Inbred F344 | 1 | 2018 | 107 | 0.040 |
Why?
|
| Capsaicin | 1 | 2017 | 20 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2019 | 289 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2012 | 910 | 0.030 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2017 | 20 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2001 | 1433 | 0.030 |
Why?
|
| Cytokines | 1 | 2003 | 1378 | 0.030 |
Why?
|
| Macrophages | 1 | 2021 | 697 | 0.030 |
Why?
|
| 1-Acylglycerol-3-Phosphate O-Acyltransferase | 1 | 2016 | 3 | 0.030 |
Why?
|
| Autophagy-Related Protein-1 Homolog | 1 | 2016 | 11 | 0.030 |
Why?
|
| Tripartite Motif Proteins | 1 | 2016 | 20 | 0.030 |
Why?
|
| Sterol Esterase | 1 | 2016 | 20 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2002 | 3131 | 0.030 |
Why?
|
| Forearm | 1 | 2016 | 47 | 0.030 |
Why?
|
| Osmosis | 1 | 2016 | 17 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2008 | 1714 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 169 | 0.030 |
Why?
|
| Lipase | 1 | 2016 | 97 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2001 | 1031 | 0.030 |
Why?
|
| Urea | 1 | 2016 | 233 | 0.030 |
Why?
|
| Epididymis | 1 | 2016 | 67 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2016 | 226 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2016 | 332 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2014 | 58 | 0.030 |
Why?
|
| Leukocytes | 1 | 2016 | 216 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 1041 | 0.030 |
Why?
|
| STAT5 Transcription Factor | 1 | 2014 | 89 | 0.030 |
Why?
|
| Aging | 1 | 2002 | 1279 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 54 | 0.030 |
Why?
|
| Models, Animal | 1 | 2016 | 483 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 453 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 392 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 592 | 0.030 |
Why?
|
| Ghrelin | 1 | 2013 | 55 | 0.030 |
Why?
|
| Incretins | 1 | 2013 | 24 | 0.030 |
Why?
|
| Uncoupling Protein 2 | 1 | 2012 | 14 | 0.020 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2012 | 19 | 0.020 |
Why?
|
| Cell Line | 2 | 2008 | 2853 | 0.020 |
Why?
|
| Cattle | 2 | 2004 | 588 | 0.020 |
Why?
|
| Molecular Docking Simulation | 1 | 2013 | 127 | 0.020 |
Why?
|
| In Vitro Techniques | 2 | 2008 | 961 | 0.020 |
Why?
|
| Placebos | 1 | 2013 | 235 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2013 | 117 | 0.020 |
Why?
|
| Aspartame | 1 | 2011 | 1 | 0.020 |
Why?
|
| Biomarkers | 2 | 2012 | 3415 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2016 | 1707 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 702 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 3960 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2020 | 3979 | 0.020 |
Why?
|
| Hydrogenation | 1 | 2011 | 3 | 0.020 |
Why?
|
| Time | 1 | 2011 | 101 | 0.020 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2011 | 32 | 0.020 |
Why?
|
| Homeostasis | 1 | 2016 | 748 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2013 | 298 | 0.020 |
Why?
|
| Beverages | 1 | 2011 | 102 | 0.020 |
Why?
|
| Soybean Oil | 1 | 2011 | 71 | 0.020 |
Why?
|
| Milk | 1 | 2011 | 123 | 0.020 |
Why?
|
| Postmenopause | 1 | 2011 | 155 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 3363 | 0.020 |
Why?
|
| Amino Acids | 1 | 2013 | 685 | 0.020 |
Why?
|
| Mutation | 2 | 2019 | 6343 | 0.020 |
Why?
|
| Energy Intake | 1 | 2011 | 515 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2009 | 212 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1325 | 0.020 |
Why?
|
| Cardiovascular Diseases | 2 | 2011 | 2092 | 0.020 |
Why?
|
| Enzyme Activators | 1 | 2008 | 12 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 1915 | 0.020 |
Why?
|
| Glycerol | 1 | 2008 | 99 | 0.020 |
Why?
|
| Overweight | 1 | 2011 | 386 | 0.020 |
Why?
|
| Lipectomy | 1 | 2008 | 9 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2009 | 393 | 0.020 |
Why?
|
| Mammals | 1 | 2009 | 282 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 2956 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 167 | 0.020 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2012 | 429 | 0.020 |
Why?
|
| Ligands | 1 | 2008 | 571 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2008 | 839 | 0.020 |
Why?
|
| Aged | 2 | 2014 | 21497 | 0.010 |
Why?
|
| Aminoquinolines | 1 | 2004 | 35 | 0.010 |
Why?
|
| Adolescent | 2 | 2013 | 20569 | 0.010 |
Why?
|
| Tryptophan | 1 | 2004 | 100 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2004 | 174 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2003 | 46 | 0.010 |
Why?
|
| Isoleucine | 1 | 2003 | 30 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 304 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2004 | 631 | 0.010 |
Why?
|
| Alanine | 1 | 2003 | 184 | 0.010 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2003 | 51 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 7139 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2003 | 139 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 2002 | 71 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 2002 | 43 | 0.010 |
Why?
|
| Glutamine | 1 | 2003 | 217 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 787 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2002 | 335 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 3794 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 684 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 13103 | 0.010 |
Why?
|
| Diet | 1 | 2002 | 1169 | 0.010 |
Why?
|
| Testosterone | 1 | 1999 | 622 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1999 | 2651 | 0.010 |
Why?
|